Autologous cytomegalovirus-specific T cells as effector cells in immunotherapy of B cell chronic lymphocytic leukaemia
- 9 July 2004
- journal article
- Published by Wiley in British Journal of Haematology
- Vol. 126 (4) , 512-516
- https://doi.org/10.1111/j.1365-2141.2004.05070.x
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Human CD8+ T-cell differentiation in response to virusesNature Reviews Immunology, 2003
- Expansion of CMV-specific CD8+CD45RA+CD27- T cells in B-cell chronic lymphocytic leukemiaBlood, 2003
- Proliferation Requirements of Cytomegalovirus-Specific, Effector-Type Human CD8+ T CellsThe Journal of Immunology, 2002
- T-cell responses against chronic lymphocytic leukemia cells: implications for immunotherapyBlood, 2002
- T-cell-receptor gene therapyNature Reviews Immunology, 2002
- Functional Characterization of an Endosome-disruptive Peptide and Its Application in Cytosolic Delivery of Immunoliposome-entrapped ProteinsJournal of Biological Chemistry, 2002
- Sensitization of tumour cells to lysis by virus-specific CTL using antibody-targeted MHC class I/peptide complexesBritish Journal of Cancer, 2000
- Gene transfer of CD40-ligand induces autologous immune recognition of chronic lymphocytic leukemia B cells.Journal of Clinical Investigation, 1998
- Activated T cells induce expression of B7/BB1 on normal or leukemic B cells through a CD40-dependent signal.The Journal of Experimental Medicine, 1993